• Skip to primary navigation
  • Skip to main content
Butchertown Clinical Trials

Butchertown Clinical Trials

Paid Clinical Trials in Louisville, KY

  • Blog
  • Patients
    • Currently Enrolling Clinical Trials
    • Process
    • FAQs
  • Partners
    • Physicians
    • Sponsors and CROs
    • Become a Physician Partner
    • Facility, Equipment, and Capabilities
  • About
    • Contact
    • Research Team
    • Dry Eye Research and Clinical Trials
    • Diversity, Equity, and Inclusion
    • Leave a Review
  • Show Search
Hide Search

Butchertown Clinical Trials and The Eye Care Institute Announce 21st FDA Approval

Mark Prussian · March 14, 2024 ·

LOUISVILLE, KENTUCKY, UNITED STATES, March 11, 2024 /EINPresswire.com/ — Formosa Pharmaceuticals, Inc., Songshan Dist., Taipei City 105, Taiwan, announced the U.S. Food and Drug Administration (FDA) approved Clobetasol propionate ophthalmic suspension, 0.05% (APP13007) for the treatment of ocular inflammation and pain following ocular surgery.

Dr. Brennan P. Greene, MD. continued “Although much work remains to eradicate post-operative pain and inflammation, this is another good choice for treating some of the seven million people per year who undergo eye surgery in the United States.”

Clobetasol propionate ophthalmic suspension is another excellent addition to the family of medicines that help treat inflammation and pain following eye surgery.”

— Dr. Brennan Greene, Principal Investigator

Mark Prussian, CEO of Butchertown Clinical Trials, said, “I find it especially gratifying when research institutions affiliate to create a drug such as this. In this case, Formosa is working with our previous clinical trial partner, Eyenovia, to market and commercialize the drug, which is also a development partner with Senju, with whom we have also partnered on other clinical trials.”

This is the 21st FDA-approved drug or device for Louisville, KY-based Butchertown Clinical Trials, a division of The Eye Care Institute. Mark Prussian stated each FDA approval is a breakthrough for medicine and for the improvement of the lives of our patients.

# # #

For more information:

Mark Prussian
Butchertown Clinical Trials

+1 502-589-1500
email us here

Visit us on social media:

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Butchertown Clinical Trials and The Eye Care Institute Announce Our 20th FDA Approval Qlosi™, an Eyedrop for the Treatment of Presbyopia
We Have Been Named a Top Workplace in Kentucky

Press Releases

best places

Butchertown Clinical Trials
205 N. Spring Street
Louisville, KY 40206

502-219-7700
Mon-Fri, 8am – 5pm

Contact Us

bct logo

Butchertown Clinical Trials is an Ophthalmic, Vaccine, Adult Medicine and Metabolic Disease Clinical Trials Research Site in Louisville, KY

eci logo

Our parent company, The Eye Care Institute, are Leaders in LASIK ® and multiple other ways to improve your vision

bbb

Copyright © 2025 · Butchertown Clinical Trials, All Rights Reserved

Website designed and supported by Louisville Web Nerds